Drug Pipeline

Tropisetron Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Early Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07413809 Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs… Multiple Myeloma Recruiting
Early Phase 1
NCT07348172 Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings Drug Liking Not Yet Recruiting
Not specified
NCT07554040 Amisulpride for the Prevention of Postoperative Nausea and Vomiting in Patients… PONV Not Yet Recruiting
Sponsors Running Tropisetron Trials
Stanford University (1) The Affiliated People's Hospital of Ningbo University (1) Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Disease Areas
Multiple Myeloma (1)
Get alerts when Tropisetron trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free